Use of Modified oligo-beta -(1,3)-glucans for the Treatment of Diseases of the Immune System, oligo-beta -(1,3)-glucan-(1,3)-mannose, oligo-beta -(1,3)-glucan-(1,3)-mannitol and their Derivatives - Université de Rennes Accéder directement au contenu
Brevet Année : 2008

Use of Modified oligo-beta -(1,3)-glucans for the Treatment of Diseases of the Immune System, oligo-beta -(1,3)-glucan-(1,3)-mannose, oligo-beta -(1,3)-glucan-(1,3)-mannitol and their Derivatives

Domaines

Chimie organique
Fichier non déposé

Dates et versions

hal-00405831 , version 1 (21-07-2009)

Identifiants

  • HAL Id : hal-00405831 , version 1

Citer

Jean-Claude Yvin, Karine Descroix, Vincent Ferrières, Frank Jamois, Isabelle Laurent, et al.. Use of Modified oligo-beta -(1,3)-glucans for the Treatment of Diseases of the Immune System, oligo-beta -(1,3)-glucan-(1,3)-mannose, oligo-beta -(1,3)-glucan-(1,3)-mannitol and their Derivatives. Patent n° : 2910322. 2008. ⟨hal-00405831⟩
46 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More